Abstract
Supplementation with vitamin D3 showed no advantage over placebo in reducing risk of depression among adults ages 50 and older, a randomized controlled trial has found. No significant differences between vitamin D3 and placebo were found for study population subgroups, including Black adults, who experience low levels of vitamin D3 in higher numbers. Results of the trial were published Aug. 4 in JAMA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
